Morgan Dempsey Capital Management’s Pfizer PFE Stock Holding History

Morgan Dempsey Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-400	Closed	-$9.96K	–	155
2025 Q4	$9.96K	Hold	400	–	–	﹤0.01%	122
2025 Q3	$10.2K	Buy	+400	New	+$9.87K	﹤0.01%	129
2025 Q2	–	Sell	-400	Closed	-$10.1K	–	159
2025 Q1	$10.1K	Hold	400	–	–	﹤0.01%	110
2024 Q4	$10.6K	Hold	400	–	–	﹤0.01%	102
2024 Q3	$11.6K	Hold	400	–	–	﹤0.01%	97
2024 Q2	$11.2K	Hold	400	–	–	﹤0.01%	86
2024 Q1	$11.1K	Hold	400	–	–	﹤0.01%	87
2023 Q4	$11.5K	Buy	400 +100	+33%	+$3.02K	﹤0.01%	83
2023 Q3	$9.95K	Buy	+300	New	+$10.6K	﹤0.01%	88
2023 Q1	–	Sell	-200	Closed	-$10.2K	–	148
2022 Q4	$10.2K	Hold	200	–	–	﹤0.01%	113
2022 Q3	$9K	Hold	200	–	–	﹤0.01%	115
2022 Q2	$10K	Hold	200	–	–	﹤0.01%	83
2022 Q1	$10K	Hold	200	–	–	﹤0.01%	87
2021 Q4	$12K	Hold	200	–	–	﹤0.01%	84
2021 Q3	$9K	Buy	+200	New	+$8.86K	﹤0.01%	87

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Morgan Dempsey Capital Management's PFE Position: Q1 2026 in Review

Morgan Dempsey Capital Management reduced its Pfizer (PFE) stake by 83% in Q1 2026, selling an estimated $65.1K and leaving 496 shares worth $13.9K. The position accounts for 0.01% of the portfolio, ranked #110.

Morgan Dempsey Capital Management first reported a position in PFE in Q3 2015 and has held it in 35 quarters since. The position peaked at $11.8M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Morgan Dempsey Capital Management held 496 shares of Pfizer worth $13.9K as of Q1 2026.
Morgan Dempsey Capital Management sold 2,444 Pfizer shares in Q1 2026, an estimated $65.1K.
Pfizer made up 0.01% of Morgan Dempsey Capital Management's portfolio in Q1 2026, its #110 holding.
Morgan Dempsey Capital Management first reported a position in Pfizer in Q3 2015 and has held it in 35 quarters since.
Morgan Dempsey Capital Management's Pfizer position peaked at $11.8M in Q4 2021.
2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Morgan Dempsey Capital Management's 13F filing for Q1 2026, filed 6 May 2026.